Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 182 results
  • Sort by
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location NCT ID

A Study of Patients' Preferences for Primary Immune Thrombocytopenia Treatment

 		Primary Immune Thrombocytopenia United States NCT07786077

A Study Comparing Effectiveness of Kesimpta® (Ofatumumab) Versus Ocrevus® (Ocrelizumab) in Real-world Practice

 		Multiple Sclerosis United States NCT07779460

A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.

 		Asthma Phase3 Argentina
France
Hungary
Poland
Romania
Slovakia
South Africa
Spain
Taiwan
View all
 NCT05776927

Remibrutinib in Real-world Clinical Practice - a Germany Sub-study (REASSERT)

 		Chronic Spontaneous Urticaria Germany NCT07642557

A Real-world Study of Treatment Patterns and Outcomes in Primary Immune Thrombocytopenia Patients Treated With Eltrombopag

 		Immune Thrombocytopenia Switzerland NCT07587723

HJB647 Phase 1b Study in Japanese Healthy Participants With Elevated Blood Pressure and Patients With Hypertension

 		Elevated Blood Pressure, Hypertension Phase1 Japan NCT07644364

A Study to Estimate Secukinumab Retention Rate in Psoriasis Patients With MASLD

 		Plaque Psoriasis, Metabolic Dysfunction-Associated Steatotic Liver Disease Spain NCT07683065

A Study to Characterize the Clinical Presentation and Course of Cryptosporidium in Pediatric Participants

 		Cryptosporidiosis Kenya
Malaysia
Zambia 		NCT07716410

Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)

 		Acute Lymphoblastic Leukemia, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive, Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Phase1, Phase2 Australia
Israel
South Korea
Taiwan
View all
 NCT07387926

A Study of Real-World Characteristics, Treatment Patterns, and Outcomes Among mCRPC Patients Previously Treated With an Androgen Receptor Pathway Inhibitor, Taxane-Based Chemotherapy, and Lutetium-177 Vipivotide Tetraxetan

 		Prostatic Neoplasms, Castration-Resistant United States NCT07677267